Close Menu
Fund Focus News
    Facebook X (Twitter) Instagram
    Trending
    • How to take global exposure without buying international mutual funds
    • Why This 3-in-1 Equity Fund is a Smart Choice
    • ‘Why can’t I buy more ETFs in my pension?’ Calls grow to ease retirement fund investment cap
    • Which is Best Among FD, Mutual Funds and SCSS? – Money Insights News
    • Zerodha Launches Life Cycle Funds To Bring Target Date Investment For Indians | Here’s How It Works
    • Sebi Eases Intraday Borrowing Rules For Mutual Funds To Improve Liquidity Management
    • Should you look at the P/E ratio of mutual funds? Here’s what experts say
    • How to choose between guaranteed returns and growth-focused investments | Personal Finance
    Facebook X (Twitter) Instagram
    Fund Focus News
    • Home
    • Bonds
    • ETFs
    • Funds
    • Investments
    • Mutual Funds
    • Property Investments
    • SIP
    Fund Focus News
    Home»Investments»Here’s Why We’re Watching Clover Health Investments’ (NASDAQ:CLOV) Cash Burn Situation
    Investments

    Here’s Why We’re Watching Clover Health Investments’ (NASDAQ:CLOV) Cash Burn Situation

    October 27, 2024


    Just because a business does not make any money, does not mean that the stock will go down. For example, Clover Health Investments (NASDAQ:CLOV) shareholders have done very well over the last year, with the share price soaring by 330%. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly.

    In light of its strong share price run, we think now is a good time to investigate how risky Clover Health Investments’ cash burn is. In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth. Let’s start with an examination of the business’ cash, relative to its cash burn.

    See our latest analysis for Clover Health Investments

    A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. When Clover Health Investments last reported its June 2024 balance sheet in August 2024, it had zero debt and cash worth US$379m. Importantly, its cash burn was US$178m over the trailing twelve months. So it had a cash runway of about 2.1 years from June 2024. Arguably, that’s a prudent and sensible length of runway to have. The image below shows how its cash balance has been changing over the last few years.

    debt-equity-history-analysis
    debt-equity-history-analysis

    Notably, Clover Health Investments actually ramped up its cash burn very hard and fast in the last year, by 184%, signifying heavy investment in the business. While that’s concerning on it’s own, the fact that operating revenue was actually down 15% over the same period makes us positively tremulous. In light of the above-mentioned, we’re pretty wary of the trajectory the company seems to be on. Clearly, however, the crucial factor is whether the company will grow its business going forward. For that reason, it makes a lot of sense to take a look at our analyst forecasts for the company.

    Even though it seems like Clover Health Investments is developing its business nicely, we still like to consider how easily it could raise more money to accelerate growth. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. Many companies end up issuing new shares to fund future growth. We can compare a company’s cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one year’s operations.

    Clover Health Investments has a market capitalisation of US$2.0b and burnt through US$178m last year, which is 9.1% of the company’s market value. Given that is a rather small percentage, it would probably be really easy for the company to fund another year’s growth by issuing some new shares to investors, or even by taking out a loan.

    Even though its increasing cash burn makes us a little nervous, we are compelled to mention that we thought Clover Health Investments’ cash runway was relatively promising. We don’t think its cash burn is particularly problematic, but after considering the range of factors in this article, we do think shareholders should be monitoring how it changes over time. Separately, we looked at different risks affecting the company and spotted 3 warning signs for Clover Health Investments (of which 1 is potentially serious!) you should know about.

    Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies, and this list of stocks growth stocks (according to analyst forecasts)

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    How to choose between guaranteed returns and growth-focused investments | Personal Finance

    June 20, 2026

    Canada’s CPP Investments forms joint venture with Indian data center firm CtrlS

    June 17, 2026

    Leading the UK Investment Revolution: Featherstone Investments Unveils Next-Gen Platform

    June 17, 2026
    Leave A Reply Cancel Reply

    Top Posts

    The 3 Best Energy ETFs to Own as Oil Volatility Returns in 2026

    June 19, 2026

    The Shifting Landscape of Art Investment and the Rise of Accessibility: The London Art Exchange

    September 11, 2023

    Charlie Cobham: The Art Broker Extraordinaire Maximizing Returns for High Net Worth Clients

    February 12, 2024

    The Unyielding Resilience of the Art Market: A Historical and Contemporary Perspective

    November 19, 2023
    Don't Miss
    Mutual Funds

    How to take global exposure without buying international mutual funds

    June 20, 2026

    Dedicated international funds have been among the better-performing diversification options for Indian investors, but many…

    Why This 3-in-1 Equity Fund is a Smart Choice

    June 20, 2026

    ‘Why can’t I buy more ETFs in my pension?’ Calls grow to ease retirement fund investment cap

    June 20, 2026

    Which is Best Among FD, Mutual Funds and SCSS? – Money Insights News

    June 20, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    EDITOR'S PICK

    Primary stays busy with NYC TFA, Cal Regents pricing

    July 17, 2024

    Best ETFs in India for 2026

    March 1, 2026

    Hosken Consolidated Investments : Squirewood acquiert 1,1 million d’actions pour 144,1 millions de rands

    July 4, 2025
    Our Picks

    How to take global exposure without buying international mutual funds

    June 20, 2026

    Why This 3-in-1 Equity Fund is a Smart Choice

    June 20, 2026

    ‘Why can’t I buy more ETFs in my pension?’ Calls grow to ease retirement fund investment cap

    June 20, 2026
    Most Popular

    🔥Juve target Chukwuemeka, Inter raise funds, Elmas bid in play 🤑

    August 20, 2025

    💵 Libra responds after Flamengo takes legal action and ‘freezes’ funds

    September 26, 2025

    ₹9000 monthly SIP can help you retire at 45 with ₹2 lakh monthly pension

    May 5, 2026
    © 2026 Fund Focus News
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.